Skip to main content
Premium Trial:

Request an Annual Quote

Synaptic Pharmaceutical Purchases TimeLogic Bioinformatics System

Premium

INCLINE VILLAGE, Nev.--The bioinformatics division of TimeLogic, a hardware vendor here, announced the sale of a DeCypher ES-960 computational bioinformatics accelerator to Synaptic Pharmaceutical of Paramus, NJ. Synaptic's system administrator Romel Campbell said the TimeLogic unit's speed frees up the company's corporate server and allows research to proceed faster with higher productivity.

The computational genomics server, with unique search algorithms accelerated to supercomputing speeds by an array of parallel processors, provides the means to rapidly search through exponentially expanding DNA and protein sequence databases to find significant results. Synaptic's head of molecular biology, Christophe Gerald, said, "the enhanced computing power will let us pursue more drug leads more quickly than ever before."

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.